Publicacións en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (8)

2024

  1. [Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245

2022

  1. Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)

    Microbiology Spectrum, Vol. 10, Núm. 3

  2. SARS-CoV-2 infection in early first-trimester miscarriages: a prospective observational study

    Reproductive BioMedicine Online, Vol. 44, Núm. 1, pp. 127-130

2021

  1. Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis

    Leukemia, Vol. 35, Núm. 1, pp. 245-249

  2. Impact of recommended maternal vaccination programs on the clinical presentation of sars-cov-2 infection: A prospective observational study

    Vaccines, Vol. 9, Núm. 1, pp. 1-10

  3. Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women

    Viruses, Vol. 13, Núm. 1

  4. Perinatal outcomes of pregnancies resulting from assisted reproduction technology in SARS-CoV-2-infected women: a prospective observational study

    Fertility and Sterility, Vol. 116, Núm. 3, pp. 731-740

  5. The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis

    BMC Pregnancy and Childbirth, Vol. 21, Núm. 1